Nat Commun:新技术发现睾丸癌耐药相关基因
来源:生物谷 2015-02-27 11:49
一项科学调查研究已发现了可能驱动睾丸癌的一些新基因突变,也确定了可能导致肿瘤获得耐药的关键基因。 这项研究是第一次使用最先进的测序技术,探索睾丸生殖细胞肿瘤的细节,睾丸生殖细胞肿瘤是一种睾丸癌,在年轻男子中是最常见的癌症类型。 该项研究由Movember基金会资助,结果发表在Nature Communications杂志上,在此项研究中,科学
2015年2月27日讯 /生物谷BIOON/ --一项科学调查研究已发现了可能驱动睾丸癌的一些新基因突变,也确定了可能导致肿瘤获得耐药的关键基因。
doi:10.1038/ncomms6973
PMC:
PMID:
Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours
Kevin Litchfield, Brenda Summersgill, Shawn Yost, Razvan Sultana, Karim Labreche, Darshna Dudakia, Anthony Renwick, Sheila Seal, Reem Al-Saadi, Peter Broderick, Nicholas C. Turner, Richard S. Houlston, Robert Huddart, Janet Shipley & Clare Turnbull
Testicular germ cell tumours (TGCTs) are the most common cancer in young men. Here we perform whole-exome sequencing (WES) of 42 TGCTs to comprehensively study the cancer's mutational profile. The mutation rate is uniformly low in all of the tumours (mean 0.5 mutations per Mb) as compared with common cancers, consistent with the embryological origin of TGCT. In addition to expected copy number gain of chromosome 12p and mutation of ?KIT, we identify recurrent mutations in the tumour suppressor gene ?CDC27 (11.9%). Copy number analysis reveals recurring amplification of the spermatocyte development gene ?FSIP2 (15.3%) and a 0.4?Mb region at Xq28 (15.3%). Two treatment-refractory patients are shown to harbour ?XRCC2 mutations, a gene strongly implicated in defining cisplatin resistance. Our findings provide further insights into genes involved in the development and progression of TGCT.
版权声明 本网站所有注明“来源:生物谷”或“来源:bioon”的文字、图片和音视频资料,版权均属于生物谷网站所有。非经授权,任何媒体、网站或个人不得转载,否则将追究法律责任。取得书面授权转载时,须注明“来源:生物谷”。其它来源的文章系转载文章,本网所有转载文章系出于传递更多信息之目的,转载内容不代表本站立场。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。